The value of patents to biotechnology innovation cannot be understated. They enable innovators time to recoup the massive development costs of a new biotech product. Strong intellectual property measures are necessary to advance biotechnology innovation, the creation of high-wage, high-value jobs, and the ability to bring life-saving treatments and cures to market.
BIO works with the United States Patent and Trademark Office’s (USPTO) IP attaché program, which strives to improve Intellectual property (IP) systems internationally for the benefit of U.S. stakeholders. IP attachés are posted at U.S. missions around the world to address IP issues arising in their assigned regions.
Biotechnology companies rely on their patents to support the massive investment needed to develop and bring to market the next generation of innovations in healthcare, agriculture and energy.
BIO's IP Counsels Committee Conference offers timely, relevant educational sessions on the latest issues in the biotech IP sector. Attend informal networking events designed to promote discussion and foster relationships among industry colleagues.
Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.
